Hydroxypropyl-methylcellulose and GlicoPro® Eyedrops in the Treatment of Dry Eye Disease: Clinical Study
Launched by UNIVERSITY OF MILAN · Dec 9, 2024
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>18 years
- • Ocular Surface Disease Index (OSDI) \>12 AND \<65
- • Fluorescein breakup time (FBUT) \<10 seconds OR (Oxford staining Score \>1 AND \<4).
- Exclusion Criteria:
- • Systemic or ocular diseases with known effect on tear film and ocular surface
- • Systemic or ocular medications with known effect on tear film and ocular surface
- • Contact lens wearing,
- • Ocular surgery in the 12 months before enrollment
- • Known allergy or poor tolerance to any ingredient of the study products
- • Presumed poor compliance to study procedures.
About University Of Milan
The University of Milan is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university actively sponsors clinical trials aimed at enhancing healthcare outcomes and fostering innovation in medical science. Its research initiatives are guided by a dedication to ethical standards and rigorous scientific methodologies, ensuring that trials not only contribute to the body of knowledge but also prioritize patient safety and well-being. Through its extensive network of researchers and clinicians, the University of Milan plays a pivotal role in translating scientific discoveries into practical applications that benefit communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mesina, , Italy
Patients applied
Trial Officials
Edoardo Villani, MD
Study Director
University of Milan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported